Imaging microglial activation during neuroinflammation and Alzheimer's disease

Sriram Venneti1, Clayton A Wiley, Julia Kofler

  • 1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA. Sriram.Venneti@uphs.upenn.edu

Insights

Microglial activation plays a dual role in neurodegeneration, causing both harm and beneficial amyloid clearance. Advanced imaging techniques, like positron emission tomography, can track these inflammatory processes in vivo.

Area of Science:

  • Neuroscience
  • Immunology
  • Medical Imaging

Background:

  • Microglial activation is a key factor in neurodegenerative diseases, exhibiting both detrimental and beneficial effects.
  • These inflammatory processes are implicated in conditions like Alzheimer's disease, influencing amyloid plaque dynamics.
  • Microglial activity is crucial for amyloid clearance, particularly following immunotherapy.

Purpose of the Study:

  • To explore the complex role of microglial activation in neurodegenerative diseases.
  • To highlight the potential of in vivo imaging techniques for studying microglial function.
  • To assess the utility of imaging for monitoring disease progression and therapeutic efficacy.

Main Methods:

  • In vivo imaging of microglia using confocal or two/multiphoton microscopy in live subjects.
  • Positron emission tomography (PET) scanning in human subjects utilizing translocator protein-18 kDa (TSPO) ligands.
  • Longitudinal studies to observe microglial dynamics over time in their native environment.

Main Results:

  • In vivo microscopy allows for real-time observation of microglial behavior in their natural setting.
  • TSPO-targeted PET imaging provides a measure of neuroinflammation in human subjects.
  • Imaging can potentially track disease progression and evaluate the effectiveness of treatments targeting microglial activation.

Conclusions:

  • Microglial activation is a significant component of neurodegenerative pathogenesis with complex consequences.
  • In vivo imaging offers powerful tools to investigate microglial dynamics in aging and disease.
  • PET imaging of TSPO ligands can serve as a biomarker for disease monitoring and therapeutic response.

Related Concept Videos